|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0029925,
umls-concept:C0178602,
umls-concept:C0439230,
umls-concept:C0522510,
umls-concept:C1272706,
umls-concept:C1442162,
umls-concept:C1511572,
umls-concept:C1550718,
umls-concept:C2603343,
umls-concept:C2825407
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1993-9-21
|
|
pubmed:abstractText |
The importance of dose intensity has not been clearly defined in ovarian cancer and we present a prospectively randomised trial of dose intensity in patients with ovarian cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
377-83
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8353072-Adenocarcinoma,
pubmed-meshheading:8353072-Adult,
pubmed-meshheading:8353072-Aged,
pubmed-meshheading:8353072-Antineoplastic Agents,
pubmed-meshheading:8353072-Drug Administration Schedule,
pubmed-meshheading:8353072-Female,
pubmed-meshheading:8353072-Humans,
pubmed-meshheading:8353072-Middle Aged,
pubmed-meshheading:8353072-Ovarian Neoplasms,
pubmed-meshheading:8353072-Prospective Studies,
pubmed-meshheading:8353072-Survival Rate
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles.
|
|
pubmed:affiliation |
CRC Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, U.K.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
